Common and rare arterial collateral pathways are reviewed by 3D volume-rendered CT images. Visceral and lower extremity arterial embryology is reviewed.
Twenty-two patients with malignant biliary obstruction and 21 patients with suspected obstruction of biliary-enteric anastomoses were evaluated over a 12-month period with magnetic resonance (MR) cholangiography and cross-sectional MR imaging. In patients with malignant obstruction, MR cholangiography helped accurately determine the status of the biliary ductal system by identifying the exact location and extent of the obstruction and the severity of duct dilatation. In so doing, MR cholangiography helped determine whether percutaneous transhepatic cholangiography with antegrade stent placement or retrograde cholangiography with stent placement constituted the more suitable treatment. Cross-sectional MR imaging was necessary to identify the organ of tumor origin, define the tumor margins, and determine the stage of disease. This information helped evaluate the appropriateness of curative surgical therapy versus palliative drainage procedures. In patients with biliary-enteric anastomoses, MR cholangiography clearly depicted the site of the anastomosis and demonstrated the status of the intrahepatic ducts, thereby helping determine which patients would benefit from undergoing antegrade duct cannulation with a drainage procedure or perhaps balloon dilation. In some of these patients, MR cholangiography was sufficient to help plan therapeutic intervention. MR cholangiography also demonstrates the presence and size of biliary stones and associated findings such as intraductal tumor growth. In addition, MR cholangiography may obviate retrograde cholangiography, which can be technically difficult to perform.
Despite the promising
results from the placement of covered or
uncovered self-expandable metallic stent (SEMS) as a nonsurgical therapeutic
option for the malignant gastric outlet obstruction (GOO), the long
patency of the stent is still limited because of stent-induced tissue
hyperplasia. Here, a local heat treatment using a nanofunctionalized
SEMS is proposed for suppressing stent-induced tissue hyperplasia
during GOO treatment. Highly efficient photothermal gold nanoparticle
(GNP) transducer-coated SEMSs (GNP-SEMSs) were prepared for local
heat treatment in rat gastric outlet. The in vivo heating temperature
in rat gastric outlet model was evaluated and compared with in vitro
heating temperature. Three groups of our developed 45 rat gastric
outlet models were used: group A, noncoated SEMS only; group B, GNP-SEMS
plus local heating; and group C, GNP-SEMS only to investigate in vivo
efficacy of GNP-SEMS mediated local heating. Ten rats per group were
sacrificed for 4 weeks, and five rats per group were sacrificed immediately
after local heat treatment. The in vivo heating temperature was found
to be 10.8% lower than the in vitro heating temperatures. GNP-SEMSs
were successfully placed through a percutaneous approach into the
rat gastric outlet (n = 45). The therapeutic effects
of GNP-SEMS were assessed by histologic examination including hematoxylin-eosin,
Masson trichrome, immunohistochemistry (TUNEL and CD31), and immunofluorescence
(Ki67), and the results showed significant prevention of tissue hyperplasia
following stent placement without adjacent gastrointestinal tissue
damage. GNP-SEMS-mediated local heating could be an alternative therapeutic
option for the suppression of tissue hyperplasia following stent placement
in benign and malignant GOOs.
High serum 18OHB in APA reflects augmented production of both 18OHB and A, not disproportionate 18OHB secretion relative to A. The 18OHB/A and 18OHB/F gradients are useful adjuncts but not as reliable as A/F gradients for A lateralization during AVS.
Resistance to doxorubicin based chemotherapy is a major therapeutic problem limiting advanced breast cancer treatment. 99mTc hexakis-2-methoxyisobutylisonitrile ((99m)Tc-MIBI) has been reported to be extruded from tumour cells by the P-glycoprotein and multidrug resistance protein encoded by MDR1 and MRP1 genes, respectively. These proteins are involved in the cellular efflux of several chemotherapeutic agents including doxorubicin. The aim of this study was to investigate the clinical value of a standard (99m)Tc-MIBI scintimammography technique in the prediction of response to chemotherapy in advanced breast cancer patients. Fifty-six lesions from 33 female patients with locally advanced (n=27) or recurrent breast cancer (n=6) were included in the study. MIBI scintigraphy was performed 2-8 days prior to chemotherapy (FAC regimen). Images were acquired 10 min and 1 h post-injection of 740-1110 MBq of (99m)Tc-MIBI. Tumour-to-normal background tissue uptake ratios were calculated on each lesion in the early (T/B(e)) and delayed phase of the study (T/B(d)). Both T/B(e) and T/B(d) ratios were significantly higher (P<0.0001) in responders (n=43) than nonresponders (n=13). Diagnostic values of (99m)Tc-MIBI in the prediction of chemotherapy response were evaluated using the arbitrary cut-off values of 1.5 for T/B(e) and 1.4 forT/B(d). Sensitivity, specificity, positive and negative predictive values were 88.4%, 92.3%, 97.4%, 70.6%; and 90.7%, 100.0%, 100.0%, 76.6%, for T/B(e) and T/B(d), respectively. We conclude that (99m)Tc-MIBI scintigraphy may be a clinically valuable tool for guiding chemotherapy in advanced breast cancer patients.
Vascular injuries related to misplacement of fixation screws are relatively infrequent but potential life and limb-threatening complications that require early recognition with prompt repair of vascular lesions and screw reposition.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.